+1 888-880-9539Search News by Tag: immunotherapy
121 news stories found
Press Release
June 6, 2026
Smart nanoparticles turn 'cold' tumors hot: A new era in cancer immunotherapy
Read Press Release
Press Release
May 30, 2026
The Humanized Mouse Platform of Alfa Cytology Facilitates Preclinical Studies of Immunotherapy Drugs
Alfa Cytology offers huPBMC and huHSC humanized mouse models and in vivo immunotherapy testing for preclinical immunotherapy drug research.
Read Press Release
Press Release
May 26, 2026
Creative Biolabs introduces custom cell-based artificial T-cell stimulator development services, featuring antigen-specific CD4+ and CD8+ platforms, to accelerate CAR-T and TIL cell therapy research and streamline in vitro immunotherapy evaluation.
Read Press Release
Press Release
May 25, 2026
In response to growing demand for integrated mRNA research solutions, Creative Biolabs provides a broad portfolio of services and products designed to support early-stage and translational mRNA immunotherapy programs.
Read Press Release
Press Release
May 22, 2026
Creative Biolabs, a leading biotechnology CRO, has expanded its complement therapeutics and macrophage research solutions to support advanced immunology studies.
Read Press Release
Press Release
April 25, 2026
Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs).
Read Press Release
Press Release
April 25, 2026
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Read Press Release
Press Release
April 25, 2026
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.
Read Press Release
Press Release
April 24, 2026
Targeting glutamine metabolism to enhance CAR-macrophage efficacy in solid tumors
Read Press Release
Press Release
April 22, 2026
Creative Biolabs, a global leader in antibody engineering, has announced the expansion of its integrated suite of solutions focused on antibody-dependent cellular cytotoxicity (ADCC).
Read Press Release
Press Release
April 18, 2026
Breast cancer special issue spotlights AI while widening the view of precision care
Read Press Release
Press Release
March 31, 2026
Alfa Cytology provides in vivo research support for tumor studies and immunotherapy using cancer animal models and humanized immune system mice.
Read Press Release
Press Release
March 16, 2026
Chris is a dedicated clinical research professional with over 25 years in the development of novel therapies for patients with high unmet need
Read Press Release
Press Release
January 8, 2026
Alfa Cytology provides in vitro and in vivo models of cancer and Next-Gen PBMC humanized PDX platform for tumor research and immuno-oncology studies.
Read Press Release
Press Release
November 25, 2025
Creative Biolabs launches a comprehensive CDMO solutions to match the exact needs of CAR-T cell therapies.
Read Press Release
Press Release
November 22, 2025
Alfa Cytology today unveils its innovative endogenous T-cell engagement system (ETES™) platform.
Read Press Release
Press Release
November 6, 2025
Terry Guido Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who
Terry Guido has been endorsed by Marquis Who's Who as a leader in the field of pathology
Read Press Release
Press Release
September 19, 2025
Creative Biolabs has unparalleled experience in immunotherapy modeling and offers a full suite of services that address every facet of CAR-T development.
Read Press Release
Press Release
August 27, 2025
Nan Li is recognized for one year of dedicated service in the health care industry
Read Press Release